Entera Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Entera Bio (ENTX).

Price Target Range — 8 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingOutperform# Analysts5Avg. Consensus PT$10Upside to Avg. PT+219.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 25, 2026	Guggenheim	Vamil Divan	Initiate	Buy	$11
Sep 23, 2026	LifeSci Capital	Patrick Dolezal	Initiate	Outperform	$10
Sep 22, 2026	Cantor Fitzgerald	Imogen Mansfield	Initiate	Overweight	—
Sep 18, 2026	Leerink Partners	David Risinger	Initiate	Outperform	$9
Apr 27, 2026	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$10→$9
Feb 9, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Mar 18, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Nov 11, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Oct 7, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Sep 27, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Aug 12, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Jun 5, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
May 14, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
May 13, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Apr 2, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Dec 11, 2023	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Guggenheim Initiates Coverage On Entera Bio with Buy Rating, Announces Price Target of $11

Guggenheim analyst Vamil Divan initiates coverage on Entera Bio (NASDAQ:ENTX) with a Buy rating and announces Price Target of $11.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Initiates Coverage On Entera Bio with Overweight Rating

Cantor Fitzgerald analyst Imogen Mansfield initiates coverage on Entera Bio (NASDAQ:ENTX) with a Overweight rating.

Benzinga Newsdesk

PRO
Leerink Partners Initiates Coverage On Entera Bio with Outperform Rating, Announces Price Target of $9

Leerink Partners analyst David Risinger initiates coverage on Entera Bio (NASDAQ:ENTX) with a Outperform rating and announces Price Target of $9.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Entera Bio, Lowers Price Target to $9

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Entera Bio (NASDAQ:ENTX) with a Buy and lowers the price target from $10 to $9.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price target.

Benzinga Newsdesk

Entera Bio Ltd

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Entera Bio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Guggenheim Initiates Coverage On Entera Bio with Buy Rating, Announces Price Target of $11

PRO
Cantor Fitzgerald Initiates Coverage On Entera Bio with Overweight Rating

PRO
Leerink Partners Initiates Coverage On Entera Bio with Outperform Rating, Announces Price Target of $9

PRO
HC Wainwright & Co. Maintains Buy on Entera Bio, Lowers Price Target to $9

PRO
HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

People Also Watch

People Also Watch

Entera Bio Ltd

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Entera Bio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROGuggenheim Initiates Coverage On Entera Bio with Buy Rating, Announces Price Target of $11

PROCantor Fitzgerald Initiates Coverage On Entera Bio with Overweight Rating

PROLeerink Partners Initiates Coverage On Entera Bio with Outperform Rating, Announces Price Target of $9

PROHC Wainwright & Co. Maintains Buy on Entera Bio, Lowers Price Target to $9

PROHC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

PROHC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

People Also Watch

People Also Watch

PRO
Guggenheim Initiates Coverage On Entera Bio with Buy Rating, Announces Price Target of $11

PRO
Cantor Fitzgerald Initiates Coverage On Entera Bio with Overweight Rating

PRO
Leerink Partners Initiates Coverage On Entera Bio with Outperform Rating, Announces Price Target of $9

PRO
HC Wainwright & Co. Maintains Buy on Entera Bio, Lowers Price Target to $9

PRO
HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target